Vanderbilt-Ingram Cancer Center

Vanderbilt-Ingram website >

August 29, 2022

Blood cancer progression

Vanderbilt researchers used single-cell technologies to explore the accumulation of mutations during blood cancer progression, which could help identify strategies for preventing leukemia before it occurs.

By Leigh MacMillan
VUMC’s new automated biobanking system can store as many as 10 million biospecimens.
August 25, 2022

New high-tech biobank safeguards critical specimens

By Bill Snyder
August 25, 2022

V Foundation support

Shane Jacobson, chief executive officer of the V Foundation for Cancer Research, on left, visited Vanderbilt-Ingram Cancer Center on Monday to meet with former and current recipients of funding from the foundation.

By VUMC News and Communications
August 18, 2022

Abramson, Eng, Johnson named to new VICC roles

Three physician researchers at Vanderbilt-Ingram Cancer Center are assuming additional leadership roles.

By Tom Wilemon
August 17, 2022

Trial for colorectal cancer drug reaches primary endpoint

A new therapy for metastatic colorectal cancer that has been granted fast track designation by the U.S. Food and Drug Administration has met its primary endpoint of overall survival in a phase 3 clinical trial.

By Tom Wilemon
August 11, 2022

Cell-free breast cancer “biopsy”

The circulating DNA that tumors release is a reliable metric of tumor genomics and can be used to monitor molecular changes in metastatic breast cancer.

By Sarah E. Glass
August 11, 2022

Couple’s gift helps support immunotherapy research

Luke and Susan Simons have endowed a new directorship that will support research so that more people can benefit from immunotherapies.
By Tom Wilemon
August 4, 2022

Female bladder cancer patients to benefit from new care support coordinator

A philanthropic gift of a patient care coordinator designated to assist female bladder cancer patients in education, clinical decision-making, surveillance, support and even screening, is the first of its kind at Vanderbilt University Medical Center.
By Craig Boerner
August 2, 2022

Targeted cancer drug during pregnancy

The targeted cancer therapy alectinib was safe as a treatment for lung cancer during two pregnancies in a patient with non-small cell lung cancer, according to a case report from Vanderbilt physicians.
By Leigh MacMillan
August 1, 2022

H. pylori and lung cancer

Specific biomarkers for H. pylori — a bacterium that infects the stomach — were associated with increased risk of lung cancer, Vanderbilt researchers have discovered.
By Leigh MacMillan
July 28, 2022

Study reveals need for matching targeted therapies with EGFR subtypes

A Vanderbilt study suggests that clinicians should take a deeper dive into distinguishing EGFR mutations when prescribing targeted therapies for non-small-cell lung cancers.
By Tom Wilemon
July 21, 2022

VIGH, VICC establish cancer research program in Zambia

Vanderbilt University Medical Center and the University of Zambia (UNZA) are partnering on a program to develop a cadre of researchers and educators to lead cancer epidemiology research and training in Zambia.
By Kristin Centers
June 20, 2022

Ginseng intake and mortality

Regular ginseng intake, particularly over a long duration, is associated with decreased risk of death from all causes, Vanderbilt researchers discovered in a large epidemiological study.
By Leigh MacMillan
1 … 12 13 14 15 16 … 28